MEMANTINE HYDROCHLORIDE ORAL

MEMANTINE HYDROCHLORIDE ORAL was reported 2800 times

MEMANTINE HYDROCHLORIDE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BODY TINEA 33 0.0589
1 ECHOLALIA 13 0.0409
2 SUPERFICIAL SIDEROSIS OF CENTRAL NERVOUS SYSTEM 5 0.0394
3 NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC 2 0.0370
4 BRACHIOCEPHALIC VEIN THROMBOSIS 3 0.0244
5 OROANTRAL FISTULA 5 0.0230
6 INHIBITORY DRUG INTERACTION 32 0.0202
7 OESOPHAGEAL DILATATION 7 0.0158
8 HYPONATRAEMIC SYNDROME 5 0.0155
9 INFECTION SUSCEPTIBILITY INCREASED 33 0.0151
10 DIABETIC HYPEROSMOLAR COMA 6 0.0139
11 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 13 0.0121
12 KLEBSIELLA URINARY TRACT INFECTION 3 0.0113
13 CEREBRAL MICROHAEMORRHAGE 5 0.0110
14 CEREBRAL VENTRICULAR RUPTURE 2 0.0109
15 PORIOMANIA 2 0.0105
16 AMIMIA 1 0.0091
17 ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD 1 0.0091
18 HYPORESPONSIVE TO STIMULI 10 0.0085
19 ELECTROCARDIOGRAM ST-T CHANGE 6 0.0085
20 NEUROPSYCHOLOGICAL SYMPTOMS 5 0.0083
21 ABDOMINAL WALL MASS 1 0.0082
22 DIET REFUSAL 6 0.0082
23 SPINAL CORD OEDEMA 3 0.0081
24 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
25 METASTASES TO SOFT TISSUE 2 0.0077
26 CATHETER SITE CELLULITIS 2 0.0068
27 HAEMORRHOID OPERATION 3 0.0067
28 EPIDERMOLYSIS BULLOSA 2 0.0065
29 MITRAL VALVE CALCIFICATION 4 0.0062
30 MOANING 7 0.0062
31 BASAL GANGLIA INFARCTION 2 0.0058
32 METASTASES TO CHEST WALL 2 0.0058
33 GLUCOSE TOLERANCE IMPAIRED 33 0.0056
34 DYSLALIA 4 0.0055
35 STEREOTYPY 5 0.0053
36 POVERTY OF SPEECH 2 0.0051
37 DROPPED HEAD SYNDROME 2 0.0051
38 EXCESSIVE CERUMEN PRODUCTION 3 0.0048
39 PARKINSONIAN GAIT 3 0.0048
40 DEMENTIA ALZHEIMER'S TYPE 8 0.0048
41 ADULT FAILURE TO THRIVE 1 0.0047
42 GLIOSIS 2 0.0047
43 HALLUCINATION, OLFACTORY 2 0.0046
44 SCLERAL DISCOLOURATION 3 0.0046
45 BULIMIA NERVOSA 2 0.0046
46 LACK OF SPONTANEOUS SPEECH 2 0.0046
47 INTESTINAL PSEUDO-OBSTRUCTION 4 0.0046
48 ACID BASE BALANCE ABNORMAL 1 0.0045
49 PLEUROTHOTONUS 4 0.0044
50 ABULIA 4 0.0043
51 PULMONARY VASCULAR DISORDER 2 0.0042
52 INTRACRANIAL MASS 4 0.0042
53 AGNOSIA 1 0.0042
54 VASOGENIC CEREBRAL OEDEMA 3 0.0042
55 METASTASES TO ABDOMINAL CAVITY 2 0.0041
56 HYPERNATRAEMIA 20 0.0040
57 FOAMING AT MOUTH 8 0.0040
58 MARASMUS 6 0.0039
59 MUSCLE CONTRACTURE 8 0.0039
60 LUNG CONSOLIDATION 11 0.0039
61 IMMUNE THROMBOCYTOPENIA 18 0.0039
62 PURPURA 34 0.0038
63 TRANSVERSE SINUS THROMBOSIS 2 0.0038
64 BRAIN MIDLINE SHIFT 2 0.0038
65 EXECUTIVE DYSFUNCTION 2 0.0037
66 MORNING SICKNESS 2 0.0037
67 FAILURE TO THRIVE 19 0.0037
68 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
69 DEMENTIA WITH LEWY BODIES 4 0.0036
70 SEIZURE LIKE PHENOMENA 6 0.0035
71 METASTASES TO MENINGES 8 0.0035
72 THALAMUS HAEMORRHAGE 3 0.0034
73 NON-SMALL CELL LUNG CANCER METASTATIC 3 0.0034
74 SOPOR 45 0.0034
75 DROP ATTACKS 2 0.0034
76 GRUNTING 2 0.0033
77 ANAEMIA MACROCYTIC 7 0.0033
78 NOSOCOMIAL INFECTION 7 0.0032
79 STOMA SITE HYPERGRANULATION 2 0.0032
80 AMYLOID RELATED IMAGING ABNORMALITIES 1 0.0031
81 LEFT ATRIAL DILATATION 4 0.0031
82 ANOREXIA NERVOSA 1 0.0031
83 CHOREA 5 0.0029
84 STARING 7 0.0029
85 BLOOD CHLORIDE INCREASED 5 0.0029
86 BRAIN CANCER METASTATIC 2 0.0029
87 URINE LEUKOCYTE ESTERASE POSITIVE 2 0.0029
88 CARPAL TUNNEL DECOMPRESSION 3 0.0028
89 HYPERLIPIDAEMIA 34 0.0028
90 NONINFECTIVE ENCEPHALITIS 2 0.0028
91 NODAL RHYTHM 4 0.0027
92 SPONTANEOUS HAEMATOMA 2 0.0027
93 DELUSIONAL DISORDER, UNSPECIFIED TYPE 2 0.0027
94 CATATONIA 14 0.0027
95 SUBCLAVIAN VEIN THROMBOSIS 3 0.0026
96 DISTRACTIBILITY 3 0.0026
97 KETONURIA 2 0.0025
98 ADRENAL MASS 2 0.0024
99 ORTHOSTATIC HYPOTENSION 41 0.0024
100 FEMORAL NECK FRACTURE 12 0.0023
101 PNEUMONIA ASPIRATION 58 0.0023
102 FOOD REFUSAL 2 0.0023
103 DRUG WITHDRAWAL CONVULSIONS 4 0.0022
104 IMPAIRED QUALITY OF LIFE 31 0.0022
105 DEMENTIA 60 0.0021
106 CATHETER SITE SWELLING 2 0.0021
107 CULTURE URINE POSITIVE 3 0.0021
108 BUNDLE BRANCH BLOCK 2 0.0021
109 BRAIN STEM HAEMORRHAGE 2 0.0021
110 SINUS BRADYCARDIA 20 0.0021
111 CONCOMITANT DISEASE PROGRESSION 4 0.0020
112 CEREBRAL ATROPHY 8 0.0020
113 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 2 0.0020
114 ATRIOVENTRICULAR BLOCK SECOND DEGREE 6 0.0020
115 ATRIOVENTRICULAR BLOCK COMPLETE 13 0.0019
116 COGWHEEL RIGIDITY 2 0.0019
117 METASTASES TO CENTRAL NERVOUS SYSTEM 24 0.0019
118 BRADYPNOEA 5 0.0019
119 ATRIOVENTRICULAR BLOCK FIRST DEGREE 8 0.0018
120 MYOCLONUS 22 0.0018
121 PRODUCT NAME CONFUSION 2 0.0018
122 POOR QUALITY SLEEP 39 0.0018
123 NEUROLEPTIC MALIGNANT SYNDROME 21 0.0018
124 CARBON DIOXIDE DECREASED 2 0.0017
125 NEPHROGENIC DIABETES INSIPIDUS 2 0.0017
126 LUNG CANCER METASTATIC 5 0.0017
127 MASTECTOMY 3 0.0017
128 ORAL HERPES 33 0.0017
129 ADRENAL ADENOMA 1 0.0017
130 MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0017
131 ESCHERICHIA TEST POSITIVE 2 0.0017
132 HALLUCINATIONS, MIXED 7 0.0017
133 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 17 0.0017
134 DEVICE ALARM ISSUE 3 0.0017
135 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
136 SLOW SPEECH 4 0.0016
137 CEREBRAL ARTERY EMBOLISM 2 0.0016
138 METASTATIC NEOPLASM 7 0.0016
139 DELUSION 25 0.0016
140 PERSECUTORY DELUSION 4 0.0016
141 SALIVARY HYPERSECRETION 16 0.0016
142 DECUBITUS ULCER 13 0.0016
143 EXTRADURAL HAEMATOMA 2 0.0015
144 CYTOLYTIC HEPATITIS 5 0.0015
145 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
146 PSYCHOTIC SYMPTOM 3 0.0015
147 IMPAIRED SELF-CARE 3 0.0014
148 PSYCHOMOTOR HYPERACTIVITY 24 0.0014
149 BRAIN OEDEMA 18 0.0014
150 BRONCHIAL OBSTRUCTION 2 0.0014
151 PRERENAL FAILURE 2 0.0014
152 APPENDIX DISORDER 2 0.0014
153 CARDIAC FAILURE CHRONIC 6 0.0014
154 JAW FRACTURE 3 0.0014
155 DELIRIUM 48 0.0014
156 MUTISM 2 0.0014
157 IMMOBILE 6 0.0014
158 COLONOSCOPY 3 0.0014
159 NORMOCYTIC ANAEMIA 2 0.0014
160 BRADYCARDIA 72 0.0014
161 HEPATITIS FULMINANT 4 0.0013
162 BRAIN HERNIATION 4 0.0013
163 METABOLIC ENCEPHALOPATHY 4 0.0013
164 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
165 HEAT STROKE 2 0.0013
166 IMPAIRED WORK ABILITY 28 0.0013
167 ANOSOGNOSIA 1 0.0013
168 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
169 BRUXISM 7 0.0013
170 FLAT AFFECT 3 0.0013
171 VIOLENCE-RELATED SYMPTOM 2 0.0013
172 HYPOTHERMIA 13 0.0013
173 MENTAL STATUS CHANGES 35 0.0013
174 LACUNAR INFARCTION 3 0.0013
175 HYPOPHAGIA 32 0.0013
176 OPTIC NERVE DISORDER 2 0.0012
177 CUSHINGOID 4 0.0012
178 RESPIRATORY ALKALOSIS 2 0.0012
179 BRADYPHRENIA 8 0.0012
180 BRADYARRHYTHMIA 2 0.0012
181 ASPIRATION 13 0.0012
182 MALIGNANT PLEURAL EFFUSION 2 0.0012
183 TOXIC ENCEPHALOPATHY 6 0.0012
184 ATAXIA 14 0.0012
185 SKIN WOUND 2 0.0012
186 GAZE PALSY 2 0.0012
187 BLADDER NEOPLASM 2 0.0012
188 BLOOD AMYLASE INCREASED 2 0.0012
189 CATHETER SITE PAIN 3 0.0012
190 CEREBRAL HAEMORRHAGE 41 0.0011
191 EMOTIONAL POVERTY 2 0.0011
192 BLOOD SODIUM INCREASED 3 0.0011
193 SKIN DISORDER 37 0.0011
194 ANAEMIA OF CHRONIC DISEASE 1 0.0011
195 STOMA SITE DISCHARGE 3 0.0011
196 HYPERSEXUALITY 2 0.0011
197 SINUS NODE DYSFUNCTION 2 0.0011
198 ANEURYSM RUPTURED 1 0.0011
199 BODY TEMPERATURE ABNORMAL 2 0.0011
200 DISORGANISED SPEECH 2 0.0011
201 AGITATION 79 0.0011
202 DYSENTERY 2 0.0011
203 MALNUTRITION 12 0.0011
204 STOMA SITE ERYTHEMA 2 0.0011
205 HALLUCINATION, AUDITORY 17 0.0011
206 SMALL INTESTINAL PERFORATION 2 0.0011
207 SQUAMOUS CELL CARCINOMA 10 0.0011
208 BLOOD BICARBONATE DECREASED 2 0.0011
209 BONE DENSITY DECREASED 33 0.0011
210 DUODENAL ULCER HAEMORRHAGE 3 0.0010
211 COMMUNICATION DISORDER 4 0.0010
212 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
213 HALLUCINATION, VISUAL 22 0.0010
214 ADRENAL DISORDER 2 0.0010
215 ENTEROCOLITIS 6 0.0010
216 ATRIOVENTRICULAR BLOCK 8 0.0010
217 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
218 APLASIA 2 0.0010
219 BRADYKINESIA 6 0.0010
220 POLYDIPSIA 4 0.0010
221 CEREBROVASCULAR DISORDER 3 0.0010
222 CRANIOCEREBRAL INJURY 3 0.0010
223 HYPERTENSIVE CRISIS 11 0.0010
224 PRESYNCOPE 24 0.0010
225 PROSTATITIS 3 0.0010
226 SUBARACHNOID HAEMORRHAGE 10 0.0010
227 CHEST INJURY 2 0.0010
228 AKINESIA 2 0.0010
229 MICROCYTIC ANAEMIA 2 0.0010
230 DYSKINESIA 39 0.0010
231 BLOOD LACTIC ACID INCREASED 5 0.0009
232 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
233 OPTIC NEUROPATHY 2 0.0009
234 NYSTAGMUS 5 0.0009
235 AORTIC VALVE INCOMPETENCE 4 0.0009
236 INCOHERENT 6 0.0009
237 DECREASED ACTIVITY 10 0.0009
238 HYDROCEPHALUS 5 0.0009
239 CEREBELLAR SYNDROME 2 0.0009
240 CORNEAL DISORDER 2 0.0009
241 NONSPECIFIC REACTION 5 0.0009
242 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
243 SPINAL COLUMN INJURY 2 0.0009
244 METASTASES TO SPINE 3 0.0009
245 ABNORMAL BEHAVIOUR 35 0.0009
246 BRONCHOPNEUMONIA 3 0.0009
247 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
248 METASTATIC MALIGNANT MELANOMA 2 0.0009
249 GASTRIC HAEMORRHAGE 10 0.0009
250 AORTIC THROMBOSIS 1 0.0009
251 HALLUCINATION 65 0.0009
252 HYPERREFLEXIA 3 0.0009
253 INFUSION SITE INFECTION 2 0.0009
254 PERFORMANCE STATUS DECREASED 4 0.0009
255 LOGORRHOEA 3 0.0009
256 PANCREATITIS ACUTE 19 0.0008
257 VOLVULUS 2 0.0008
258 FIBRIN D DIMER INCREASED 3 0.0008
259 HYPONATRAEMIA 47 0.0008
260 RADIUS FRACTURE 2 0.0008
261 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
262 CAROTID ARTERY OCCLUSION 3 0.0008
263 TRANSPLANT FAILURE 2 0.0008
264 RHABDOMYOLYSIS 34 0.0008
265 FREEZING PHENOMENON 3 0.0008
266 PALLOR 22 0.0008
267 CONFUSIONAL STATE 129 0.0008
268 PROTEIN TOTAL DECREASED 3 0.0008
269 SEDATION COMPLICATION 2 0.0008
270 CANCER PAIN 2 0.0008
271 METASTASES TO LUNG 9 0.0008
272 ELECTROCARDIOGRAM QT PROLONGED 28 0.0008
273 PHYSICAL DECONDITIONING 2 0.0008
274 SYNCOPE 77 0.0008
275 WOUND SECRETION 3 0.0008
276 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
277 VENOUS THROMBOSIS 3 0.0008
278 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
279 PNEUMONIA BACTERIAL 7 0.0008
280 AGGRESSION 38 0.0008
281 HYPOKINESIA 11 0.0008
282 INCONTINENCE 8 0.0008
283 CELLULITIS 38 0.0008
284 HYPERPHAGIA 3 0.0008
285 CARDIAC FAILURE ACUTE 5 0.0007
286 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
287 COMPRESSION FRACTURE 4 0.0007
288 METASTASES TO LIVER 13 0.0007
289 RESTLESSNESS 27 0.0007
290 CLUMSINESS 2 0.0007
291 DEPRESSED LEVEL OF CONSCIOUSNESS 29 0.0007
292 METASTASES TO BONE 12 0.0007
293 SUBDURAL HAEMORRHAGE 2 0.0007
294 FAECALOMA 4 0.0007
295 HYPERURICAEMIA 3 0.0007
296 ATELECTASIS 7 0.0007
297 HEMIPLEGIA 6 0.0007
298 LEUKOCYTOSIS 13 0.0007
299 PARKINSONISM 7 0.0007
300 HOSPICE CARE 7 0.0007
301 DISORIENTATION 28 0.0007
302 GRANULOCYTOPENIA 4 0.0007
303 CEREBRAL INFARCTION 17 0.0007
304 COMA SCALE ABNORMAL 2 0.0007
305 ABASIA 17 0.0007
306 ACUTE ABDOMEN 1 0.0007
307 CATARACT 40 0.0007
308 PETECHIAE 7 0.0007
309 ANGIOPLASTY 1 0.0007
310 LUNG ADENOCARCINOMA 2 0.0007
311 PEMPHIGOID 5 0.0007
312 APHASIA 20 0.0007
313 UNRESPONSIVE TO STIMULI 17 0.0007
314 EYE INJURY 2 0.0007
315 EPILEPSY 20 0.0007
316 CHEST X-RAY ABNORMAL 2 0.0007
317 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
318 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
319 HERPES ZOSTER 37 0.0006
320 HYPOALBUMINAEMIA 5 0.0006
321 BLOOD CREATININE DECREASED 2 0.0006
322 HEPATITIS B REACTIVATION 2 0.0006
323 SUBDURAL HAEMATOMA 9 0.0006
324 MIOSIS 5 0.0006
325 VENTRICULAR HYPOKINESIA 2 0.0006
326 STUPOR 2 0.0006
327 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
328 DIZZINESS POSTURAL 6 0.0006
329 POSTURE ABNORMAL 2 0.0006
330 HYPOVENTILATION 2 0.0006
331 POLYP 4 0.0006
332 SEDATION 16 0.0006
333 ENCEPHALOPATHY 15 0.0006
334 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 2 0.0006
335 DYSPHAGIA 57 0.0006
336 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
337 FLUID INTAKE REDUCED 3 0.0006
338 COGNITIVE DISORDER 28 0.0006
339 FALL 198 0.0006
340 DYSLIPIDAEMIA 3 0.0006
341 MOTOR DYSFUNCTION 6 0.0006
342 PHLEBITIS 3 0.0006
343 MUSCLE RIGIDITY 7 0.0006
344 ENDOCARDITIS 3 0.0006
345 EYE MOVEMENT DISORDER 4 0.0006
346 DYSSTASIA 17 0.0006
347 RECTAL HAEMORRHAGE 25 0.0006
348 FEMUR FRACTURE 18 0.0006
349 VENTRICULAR EXTRASYSTOLES 6 0.0006
350 URINARY INCONTINENCE 17 0.0006
351 PARTIAL SEIZURES 3 0.0006
352 SENSITIVITY TO WEATHER CHANGE 3 0.0006
353 EMBOLIC STROKE 2 0.0006
354 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
355 HAEMOLYTIC ANAEMIA 5 0.0006
356 SOMNOLENCE 112 0.0006
357 THERAPY NON-RESPONDER 25 0.0006
358 ANAL INCONTINENCE 5 0.0006
359 FACIAL BONES FRACTURE 2 0.0006
360 DEHYDRATION 74 0.0006
361 FAECES DISCOLOURED 12 0.0006
362 LIVER FUNCTION TEST ABNORMAL 16 0.0005
363 SPONDYLITIS 2 0.0005
364 DEVICE KINK 2 0.0005
365 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
366 WOUND HAEMORRHAGE 2 0.0005
367 ON AND OFF PHENOMENON 3 0.0005
368 ADENOCARCINOMA OF COLON 1 0.0005
369 IMPULSIVE BEHAVIOUR 2 0.0005
370 BLOOD POTASSIUM DECREASED 16 0.0005
371 HEMIPARESIS 9 0.0005
372 MITRAL VALVE INCOMPETENCE 6 0.0005
373 FACE INJURY 2 0.0005
374 PLEURAL EFFUSION 32 0.0005
375 TROPONIN INCREASED 4 0.0005
376 HAEMODYNAMIC INSTABILITY 4 0.0005
377 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
378 BOWEL MOVEMENT IRREGULARITY 4 0.0005
379 CLAVICLE FRACTURE 2 0.0005
380 EXERCISE TOLERANCE DECREASED 3 0.0005
381 HYPERVENTILATION 3 0.0005
382 SPEECH DISORDER 27 0.0005
383 APNOEA 4 0.0005
384 SPINAL CORD COMPRESSION 2 0.0005
385 ABDOMINAL WALL HAEMATOMA 1 0.0005
386 TORSADE DE POINTES 4 0.0005
387 PROSTATOMEGALY 2 0.0005
388 CONTUSION 49 0.0005
389 CYANOSIS 8 0.0005
390 HEAD INJURY 16 0.0005
391 DYSARTHRIA 19 0.0005
392 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
393 ANORECTAL DISORDER 1 0.0005
394 HYPOKALAEMIA 23 0.0005
395 VITAMIN B12 DEFICIENCY 2 0.0005
396 SLUGGISHNESS 5 0.0005
397 ASPHYXIA 4 0.0005
398 HICCUPS 4 0.0005
399 EXTRAVASATION 2 0.0005
400 MANIA 8 0.0005
401 SPINAL STENOSIS 2 0.0005
402 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2 0.0005
403 DRUG LEVEL INCREASED 8 0.0005
404 SUICIDAL BEHAVIOUR 2 0.0005
405 APATHY 7 0.0005
406 SCREAMING 3 0.0005
407 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
408 PURULENT DISCHARGE 2 0.0005
409 LOSS OF CONSCIOUSNESS 59 0.0005
410 NEUROTOXICITY 8 0.0005
411 BEDRIDDEN 6 0.0005
412 DYSPHEMIA 2 0.0005
413 ORAL CANDIDIASIS 6 0.0005
414 HEPATIC FUNCTION ABNORMAL 17 0.0005
415 HAEMATOCRIT DECREASED 9 0.0005
416 LUNG INFILTRATION 4 0.0005
417 ABDOMINAL ABSCESS 2 0.0005
418 RESPIRATORY RATE INCREASED 4 0.0005
419 ILEUS PARALYTIC 2 0.0004
420 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
421 DRUG-INDUCED LIVER INJURY 14 0.0004
422 JAUNDICE 12 0.0004
423 MOBILITY DECREASED 32 0.0004
424 METASTASES TO LYMPH NODES 3 0.0004
425 URINARY TRACT DISORDER 2 0.0004
426 CHROMATURIA 10 0.0004
427 PULMONARY EMBOLISM 42 0.0004
428 INFARCTION 3 0.0004
429 HIP FRACTURE 14 0.0004
430 ENCEPHALITIS 3 0.0004
431 LARGE INTESTINE POLYP 3 0.0004
432 RENAL FUNCTION TEST ABNORMAL 2 0.0004
433 PERSONALITY CHANGE 4 0.0004
434 ELECTROLYTE IMBALANCE 5 0.0004
435 RIGHT VENTRICULAR FAILURE 3 0.0004
436 VAGINAL INFECTION 2 0.0004
437 SKIN ABRASION 2 0.0004
438 EATING DISORDER 9 0.0004
439 METASTASIS 3 0.0004
440 URINARY RETENTION 14 0.0004
441 BLOOD UREA INCREASED 7 0.0004
442 CHOLESTASIS 8 0.0004
443 GENERAL PHYSICAL HEALTH DETERIORATION 48 0.0004
444 GUILLAIN-BARRE SYNDROME 2 0.0004
445 BODY TEMPERATURE DECREASED 4 0.0004
446 HYPERCALCAEMIA 5 0.0004
447 BALANCE DISORDER 35 0.0004
448 ILEUS 5 0.0004
449 HYDRONEPHROSIS 3 0.0004
450 HYPOTONIA 4 0.0004
451 FEEDING DISORDER 8 0.0004
452 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
453 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
454 ACTINIC KERATOSIS 1 0.0004
455 HYPERSOMNIA 11 0.0004
456 PRODUCT USE COMPLAINT 6 0.0004
457 METABOLIC ACIDOSIS 12 0.0004
458 CARDIAC FAILURE 30 0.0004
459 DRUG INTERACTION 59 0.0004
460 BLOOD SODIUM DECREASED 7 0.0004
461 BEHAVIOUR DISORDER 2 0.0004
462 TACHYPNOEA 5 0.0004
463 MELAENA 8 0.0004
464 SPINAL COMPRESSION FRACTURE 3 0.0004
465 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
466 CHOKING 7 0.0004
467 HEART RATE ABNORMAL 2 0.0004
468 DECREASED APPETITE 83 0.0004
469 ANAL HAEMORRHAGE 1 0.0004
470 COMA 17 0.0004
471 ACUTE PULMONARY OEDEMA 2 0.0004
472 COLECTOMY 2 0.0004
473 DISTURBANCE IN ATTENTION 19 0.0004
474 ASTHENIA 132 0.0004
475 PRESCRIBED UNDERDOSE 7 0.0004
476 PSEUDOMONAS INFECTION 3 0.0003
477 HYPERTONIA 2 0.0003
478 DRUG ABUSE 29 0.0003
479 PARANOIA 6 0.0003
480 HYSTERECTOMY 3 0.0003
481 BLOOD URIC ACID INCREASED 2 0.0003
482 URINARY TRACT INFECTION 59 0.0003
483 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
484 STRESS CARDIOMYOPATHY 2 0.0003
485 MEDICATION ERROR 19 0.0003
486 PSYCHOTIC DISORDER 10 0.0003
487 DRUG ERUPTION 6 0.0003
488 PLEURISY 2 0.0003
489 MEMORY IMPAIRMENT 46 0.0003
490 HAEMARTHROSIS 3 0.0003
491 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
492 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
493 LETHARGY 19 0.0003
494 SCHIZOPHRENIA 4 0.0003
495 SEIZURE 38 0.0003
496 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
497 CARDIOMEGALY 4 0.0003
498 IRON DEFICIENCY ANAEMIA 3 0.0003
499 SEPSIS 36 0.0003
500 CHOLANGITIS 2 0.0003
501 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
502 DIARRHOEA HAEMORRHAGIC 3 0.0003
503 HYPOTENSION 64 0.0003
504 CONDITION AGGRAVATED 97 0.0003
505 HYPERTENSION 67 0.0003
506 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
507 LIVER DISORDER 14 0.0003
508 HAEMATEMESIS 8 0.0003
509 RESPIRATORY FAILURE 23 0.0003
510 PNEUMOTHORAX 5 0.0003
511 PNEUMONIA 102 0.0003
512 DYSTONIA 6 0.0003
513 MUSCULAR WEAKNESS 35 0.0003
514 SOMNAMBULISM 2 0.0003
515 WALKING AID USER 2 0.0003
516 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
517 CORONAVIRUS INFECTION 2 0.0003
518 HAEMOGLOBIN DECREASED 31 0.0003
519 ANXIETY DISORDER 1 0.0003
520 TERMINAL STATE 2 0.0003
521 WRONG PRODUCT ADMINISTERED 2 0.0003
522 WEIGHT INCREASED 66 0.0003
523 HAEMATURIA 10 0.0003
524 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
525 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
526 RESPIRATORY ARREST 8 0.0003
527 MENTAL IMPAIRMENT 7 0.0003
528 HYPERTRANSAMINASAEMIA 2 0.0003
529 GAIT DISTURBANCE 55 0.0003
530 COORDINATION ABNORMAL 4 0.0003
531 BLOOD TEST ABNORMAL 4 0.0003
532 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
533 HYPOXIA 10 0.0003
534 DUODENAL ULCER 2 0.0003
535 HYPOTHYROIDISM 9 0.0003
536 SINUS TACHYCARDIA 4 0.0003
537 ACUTE KIDNEY INJURY 43 0.0003
538 PRODUCT SUPPLY ISSUE 2 0.0003
539 RED BLOOD CELL COUNT DECREASED 8 0.0003
540 DISEASE PROGRESSION 33 0.0003
541 DEEP VEIN THROMBOSIS 18 0.0003
542 PULMONARY THROMBOSIS 3 0.0003
543 DYSURIA 10 0.0003
544 PSYCHIATRIC SYMPTOM 2 0.0003
545 BLOOD PRESSURE DECREASED 18 0.0003
546 CEREBRAL DISORDER 2 0.0003
547 HAEMATOMA 7 0.0003
548 VENTRICULAR FIBRILLATION 3 0.0003
549 FEELING DRUNK 2 0.0003
550 PULMONARY MASS 4 0.0003
551 THINKING ABNORMAL 5 0.0003
552 THROMBOCYTOPENIA 30 0.0003
553 HYPOGLYCAEMIA 13 0.0003
554 GENERAL SYMPTOM 2 0.0003
555 BLOOD CALCIUM DECREASED 3 0.0003
556 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
557 ANGER 9 0.0003
558 PHOTOPHOBIA 5 0.0003
559 STATUS EPILEPTICUS 3 0.0003
560 APPLICATION SITE PRURITUS 6 0.0003
561 GASTRIC ULCER 5 0.0003
562 AORTIC ANEURYSM 2 0.0003
563 HYPERTHERMIA 2 0.0003
564 LIPASE INCREASED 2 0.0003
565 GLAUCOMA 5 0.0003
566 LUNG INFECTION 4 0.0003
567 PNEUMONITIS 7 0.0003
568 BASAL CELL CARCINOMA 4 0.0003
569 COVID-19 PNEUMONIA 3 0.0003
570 TREMOR 42 0.0003
571 BACTERAEMIA 3 0.0003
572 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
573 BLOOD ALBUMIN DECREASED 2 0.0003
574 CHOLECYSTITIS 3 0.0003
575 ABSCESS 4 0.0003
576 ATRIAL FLUTTER 2 0.0003
577 MOVEMENT DISORDER 8 0.0002
578 SENSORY LOSS 2 0.0002
579 MYASTHENIA GRAVIS 2 0.0002
580 PRODUCT ADMINISTRATION ERROR 5 0.0002
581 C-REACTIVE PROTEIN INCREASED 9 0.0002
582 NOCTURIA 3 0.0002
583 HYPERGLYCAEMIA 9 0.0002
584 BLOOD POTASSIUM INCREASED 4 0.0002
585 BODY TEMPERATURE INCREASED 5 0.0002
586 CONVULSION 14 0.0002
587 POLYURIA 2 0.0002
588 AORTIC DISSECTION 1 0.0002
589 VISUAL ACUITY REDUCED 8 0.0002
590 ACCIDENTAL EXPOSURE 1 0.0002
591 LEUKOPENIA 12 0.0002
592 OEDEMA PERIPHERAL 29 0.0002
593 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
594 FACE OEDEMA 4 0.0002
595 CANDIDA INFECTION 4 0.0002
596 INSOMNIA 63 0.0002
597 RENAL FAILURE ACUTE 10 0.0002
598 ABSCESS LIMB 1 0.0002
599 FACIAL PARALYSIS 2 0.0002
600 RESPIRATORY DISORDER 7 0.0002
601 CONSTIPATION 51 0.0002
602 MYDRIASIS 3 0.0002
603 ANURIA 2 0.0002
604 MULTI-ORGAN FAILURE 4 0.0002
605 OXYGEN SATURATION DECREASED 13 0.0002
606 NIGHTMARE 8 0.0002
607 PYELONEPHRITIS 2 0.0002
608 PRODUCTIVE COUGH 11 0.0002
609 APPLICATION SITE ERYTHEMA 6 0.0002
610 URINE OUTPUT DECREASED 2 0.0002
611 HEART RATE DECREASED 8 0.0002
612 PULMONARY CONGESTION 3 0.0002
613 GRIP STRENGTH DECREASED 2 0.0002
614 ATRIAL FIBRILLATION 22 0.0002
615 TRANSAMINASES INCREASED 5 0.0002
616 ISCHAEMIC STROKE 4 0.0002
617 MALIGNANT MELANOMA 3 0.0002
618 GASTROINTESTINAL INFECTION 2 0.0002
619 AKATHISIA 3 0.0002
620 ACCIDENTAL OVERDOSE 8 0.0002
621 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
622 PERIPHERAL COLDNESS 3 0.0002
623 INCREASED TENDENCY TO BRUISE 2 0.0002
624 MUSCLE TWITCHING 5 0.0002
625 GRAND MAL CONVULSION 2 0.0002
626 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
627 LACTIC ACIDOSIS 7 0.0002
628 PANCYTOPENIA 12 0.0002
629 MASS 3 0.0002
630 RENAL DISORDER 10 0.0002
631 ERYTHEMA MULTIFORME 2 0.0002
632 BLOOD CREATININE INCREASED 14 0.0002
633 HEPATIC ENCEPHALOPATHY 2 0.0002
634 PRODUCT USE IN UNAPPROVED INDICATION 53 0.0002
635 DEVICE OCCLUSION 3 0.0002
636 TARDIVE DYSKINESIA 6 0.0002
637 ARTERIOSCLEROSIS 2 0.0002
638 SEASONAL ALLERGY 3 0.0002
639 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
640 HYPOCALCAEMIA 4 0.0002
641 FRACTURE 4 0.0002
642 ARRHYTHMIA 10 0.0002
643 SPUTUM DISCOLOURED 2 0.0002
644 MUSCULOSKELETAL DISORDER 4 0.0002
645 PRODUCT PRESCRIBING ERROR 5 0.0002
646 FEELING JITTERY 4 0.0002
647 PARALYSIS 3 0.0002
648 GAIT INABILITY 7 0.0002
649 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
650 SEROTONIN SYNDROME 4 0.0002
651 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
652 AFFECT LABILITY 2 0.0002
653 SEPTIC SHOCK 9 0.0002
654 ERUCTATION 4 0.0002
655 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
656 VITAMIN D DEFICIENCY 2 0.0002
657 ASCITES 6 0.0002
658 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
659 OEDEMA 11 0.0002
660 TACHYCARDIA 18 0.0002
661 EXTRAPYRAMIDAL DISORDER 5 0.0002
662 BRAIN INJURY 2 0.0002
663 ANAEMIA 38 0.0002
664 LACRIMATION INCREASED 6 0.0002
665 PERITONITIS BACTERIAL 2 0.0002
666 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
667 SUICIDE ATTEMPT 12 0.0002
668 OSTEOPENIA 3 0.0002
669 TOXICITY TO VARIOUS AGENTS 33 0.0002
670 HEPATITIS 5 0.0002
671 EUPHORIC MOOD 2 0.0002
672 EAR DISCOMFORT 2 0.0002
673 LUNG NEOPLASM MALIGNANT 8 0.0002
674 EYE DISCHARGE 2 0.0002
675 DEAFNESS 5 0.0002
676 SUDDEN DEATH 2 0.0002
677 DIZZINESS 94 0.0002
678 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
679 RETCHING 4 0.0002
680 HYPERHIDROSIS 24 0.0002
681 BREAST CANCER METASTATIC 2 0.0002
682 BLOOD BILIRUBIN INCREASED 5 0.0002
683 SKIN LACERATION 2 0.0002
684 FATIGUE 143 0.0002
685 HEART RATE INCREASED 18 0.0002
686 BACK PAIN 42 0.0002
687 WEIGHT DECREASED 50 0.0002
688 PULMONARY OEDEMA 8 0.0002
689 ANGIOPATHY 1 0.0002
690 FISTULA 2 0.0002
691 CIRCULATORY COLLAPSE 3 0.0002
692 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
693 MYOCARDIAL ISCHAEMIA 2 0.0002
694 DERMATITIS CONTACT 2 0.0002
695 SCAB 2 0.0002
696 SUICIDAL IDEATION 16 0.0002
697 VOMITING 81 0.0002
698 HYPERKALAEMIA 6 0.0002
699 SPINAL PAIN 2 0.0002
700 ACUTE MYOCARDIAL INFARCTION 5 0.0002
701 PRODUCT ADHESION ISSUE 6 0.0002
702 PYREXIA 58 0.0002
703 MACULAR DEGENERATION 2 0.0002
704 WITHDRAWAL SYNDROME 7 0.0002
705 BLOOD PRESSURE FLUCTUATION 4 0.0002
706 RENAL IMPAIRMENT 14 0.0002
707 LOCALISED INFECTION 4 0.0002
708 NEURALGIA 4 0.0002
709 VERTIGO 10 0.0002
710 NO THERAPEUTIC RESPONSE 2 0.0002
711 SPINAL OPERATION 2 0.0002
712 AGRANULOCYTOSIS 3 0.0002
713 DYSPNOEA 91 0.0002
714 APPLICATION SITE IRRITATION 2 0.0002
715 MIDDLE INSOMNIA 3 0.0002
716 POISONING 2 0.0002
717 DERMATITIS ALLERGIC 2 0.0002
718 COLITIS 6 0.0002
719 DIABETES MELLITUS 12 0.0002
720 HEPATIC CYTOLYSIS 2 0.0002
721 PULMONARY FIBROSIS 3 0.0002
722 DRUG PRESCRIBING ERROR 3 0.0002
723 PRESCRIBED OVERDOSE 3 0.0002
724 HAEMORRHOIDS 3 0.0002
725 NODULE 2 0.0002
726 BLOOD PRESSURE ABNORMAL 3 0.0002
727 SPINAL FRACTURE 3 0.0001
728 IRRITABILITY 9 0.0001
729 MUSCULOSKELETAL STIFFNESS 13 0.0001
730 MOOD ALTERED 4 0.0001
731 RIB FRACTURE 3 0.0001
732 APPLICATION SITE RASH 2 0.0001
733 CARDIAC ARREST 12 0.0001
734 CHILLS 17 0.0001
735 RESPIRATORY DISTRESS 4 0.0001
736 PERITONITIS 3 0.0001
737 HYPOMAGNESAEMIA 2 0.0001
738 HAEMOPTYSIS 4 0.0001
739 PERIPHERAL SWELLING 22 0.0001
740 KNEE ARTHROPLASTY 3 0.0001
741 LYMPHOPENIA 2 0.0001
742 HEPATOCELLULAR INJURY 2 0.0001
743 JOINT INJURY 3 0.0001
744 BRONCHOSPASM 2 0.0001
745 LIVER FUNCTION TEST INCREASED 3 0.0001
746 CARDIOGENIC SHOCK 2 0.0001
747 MYELOSUPPRESSION 5 0.0001
748 NAUSEA 109 0.0001
749 PRODUCT PRESCRIBING ISSUE 3 0.0001
750 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
751 CRYING 5 0.0001
752 CARDIAC FAILURE CONGESTIVE 11 0.0001
753 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
754 SKIN HAEMORRHAGE 2 0.0001
755 EYE SWELLING 5 0.0001
756 DEPRESSED MOOD 7 0.0001
757 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
758 INFECTION 19 0.0001
759 CEREBROVASCULAR ACCIDENT 22 0.0001
760 OVERDOSE 28 0.0001
761 PERICARDIAL EFFUSION 3 0.0001
762 PRODUCT DOSE OMISSION ISSUE 38 0.0001
763 MUSCULOSKELETAL CHEST PAIN 2 0.0001
764 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
765 CARDIAC DISORDER 12 0.0001
766 TREATMENT NONCOMPLIANCE 7 0.0001
767 BRAIN FOG 2 0.0001
768 AFFECTIVE DISORDER 1 0.0001
769 OFF LABEL USE 111 0.0001
770 RESPIRATORY TRACT CONGESTION 2 0.0001
771 DIABETIC KETOACIDOSIS 3 0.0001
772 THROMBOSIS 10 0.0001
773 RHINORRHOEA 8 0.0001
774 MUSCLE TIGHTNESS 2 0.0001
775 DRY MOUTH 10 0.0001
776 BACK DISORDER 2 0.0001
777 AMNESIA 8 0.0001
778 BLINDNESS 5 0.0001
779 IMPAIRED HEALING 4 0.0001
780 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
781 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
782 CARDIO-RESPIRATORY ARREST 5 0.0001
783 DEPRESSION 27 0.0001
784 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
785 DIARRHOEA 75 0.0001
786 DIPLOPIA 3 0.0001
787 MIGRAINE 11 0.0001
788 RESPIRATORY TRACT INFECTION 3 0.0001
789 EOSINOPHILIA 2 0.0001
790 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
791 LYMPHOCYTE COUNT DECREASED 2 0.0001
792 LYMPHADENOPATHY 4 0.0001
793 PLATELET COUNT DECREASED 12 0.0001
794 DEVICE ISSUE 10 0.0001
795 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
796 BLOOD PRESSURE INCREASED 17 0.0001
797 UNDERDOSE 8 0.0001
798 NEPHROLITHIASIS 5 0.0001
799 ABNORMAL DREAMS 3 0.0001
800 NECK PAIN 6 0.0001
801 MALAISE 47 0.0001
802 SWELLING 10 0.0001
803 DYSPNOEA EXERTIONAL 4 0.0001
804 INTESTINAL OBSTRUCTION 4 0.0001
805 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
806 FLATULENCE 6 0.0001
807 RENAL FAILURE 14 0.0001
808 BLOOD URINE PRESENT 2 0.0001
809 PROTEINURIA 2 0.0001
810 ANGINA PECTORIS 3 0.0001
811 LOWER LIMB FRACTURE 2 0.0001
812 ACUTE RESPIRATORY FAILURE 2 0.0001
813 DRUG INTOLERANCE 10 0.0001
814 CHEST PAIN 19 0.0001
815 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
816 KIDNEY INFECTION 2 0.0001
817 UPPER LIMB FRACTURE 2 0.0001
818 COUGH 28 0.0001
819 SLEEP DISORDER 7 0.0001
820 INTENTIONAL SELF-INJURY 2 0.0001
821 ABDOMINAL PAIN 23 0.0001
822 PAIN IN EXTREMITY 29 0.0001
823 BONE MARROW FAILURE 2 0.0001
824 DRUG ADMINISTRATION ERROR 3 0.0001
825 THERAPY CESSATION 5 0.0001
826 EMOTIONAL DISORDER 3 0.0001
827 HEADACHE 61 0.0001
828 VISUAL IMPAIRMENT 12 0.0001
829 TREATMENT FAILURE 8 0.0001
830 NERVOUS SYSTEM DISORDER 3 0.0001
831 POLLAKIURIA 4 0.0001
832 PRODUCT USE ISSUE 18 0.0001
833 NERVOUSNESS 5 0.0001
834 MUSCULOSKELETAL PAIN 5 0.0001
835 DEATH 82 0.0001
836 CYSTITIS 3 0.0001
837 DRUG INEFFECTIVE 124 0.0001
838 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
839 INTENTIONAL OVERDOSE 6 0.0001
840 NIGHT SWEATS 3 0.0001
841 DEVICE DISLOCATION 4 0.0001
842 MENTAL DISORDER 4 0.0001
843 MYOCARDIAL INFARCTION 16 0.0001
844 CHOLELITHIASIS 3 0.0001
845 INTENTIONAL PRODUCT MISUSE 8 0.0001
846 COVID-19 16 0.0001
847 HOSPITALISATION 14 0.0001
848 STAPHYLOCOCCAL INFECTION 3 0.0001
849 APPLICATION SITE PAIN 2 0.0001
850 INFUSION RELATED REACTION 6 0.0001
851 BLOOD GLUCOSE INCREASED 17 0.0001
852 VIRAL INFECTION 3 0.0001
853 EYE PRURITUS 3 0.0001
854 SNEEZING 2 0.0001
855 THROAT IRRITATION 4 0.0001
856 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
857 PRODUCT AVAILABILITY ISSUE 2 0.0001
858 ABDOMINAL PAIN UPPER 18 0.0001
859 GASTRIC DISORDER 3 0.0001
860 SHOCK 2 0.0001
861 RASH MACULAR 3 0.0001
862 BLOOD CHOLESTEROL INCREASED 4 0.0001
863 WHEEZING 5 0.0001
864 OCULAR HYPERAEMIA 4 0.0001
865 ABDOMINAL DISCOMFORT 14 0.0001
866 BRONCHITIS 6 0.0001
867 INFLUENZA 9 0.0001
868 HYPOAESTHESIA 12 0.0001
869 VISION BLURRED 11 0.0001
870 UNEVALUABLE EVENT 6 0.0001
871 CHRONIC KIDNEY DISEASE 6 0.0001
872 INFLAMMATION 4 0.0001
873 SKIN ULCER 2 0.0001
874 ANXIETY 22 0.0001
875 PRODUCT DOSE OMISSION 5 0.0001
876 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
877 GASTRITIS 2 0.0001
878 PANCREATITIS 4 0.0001
879 ADVERSE REACTION 1 0.0001
880 FEAR 2 0.0001
881 EXTRA DOSE ADMINISTERED 3 0.0001
882 LIMB INJURY 2 0.0001
883 NEUTROPHIL COUNT DECREASED 3 0.0001
884 ACUTE HEPATIC FAILURE 1 0.0001
885 SKIN LESION 2 0.0001
886 HAEMATOCHEZIA 4 0.0001
887 ANAPHYLACTIC REACTION 4 0.0001
888 DIVERTICULITIS 2 0.0001
889 PROCEDURAL PAIN 2 0.0001
890 WOUND 2 0.0001
891 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
892 FEELING ABNORMAL 17 0.0001
893 MUSCLE SPASMS 13 0.0001
894 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
895 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
896 INTENTIONAL DOSE OMISSION 2 0.0001
897 ARTHRALGIA 29 0.0001
898 EYE IRRITATION 4 0.0001
899 PANCREATIC CARCINOMA 2 0.0001
900 ANOSMIA 1 0.0001
901 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
902 CHEST DISCOMFORT 7 0.0001
903 BONE PAIN 4 0.0001
904 ERYTHEMA 14 0.0001
905 LABORATORY TEST ABNORMAL 2 0.0001
906 DYSGEUSIA 5 0.0001
907 ABDOMINAL DISTENSION 7 0.0001
908 HEPATIC FAILURE 2 0.0001
909 THERAPEUTIC RESPONSE DECREASED 4 0.0001
910 ILL-DEFINED DISORDER 4 0.0001
911 TINNITUS 3 0.0001
912 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
913 ARTHRITIS 5 0.0001
914 DISEASE RECURRENCE 3 0.0001
915 MOOD SWINGS 2 0.0001
916 INTERSTITIAL LUNG DISEASE 3 0.0001
917 SWELLING FACE 4 0.0001
918 LUNG DISORDER 3 0.0001
919 ALOPECIA 12 0.0001
920 DYSPEPSIA 6 0.0001
921 EYE DISORDER 2 0.0001
922 COMPLETED SUICIDE 5 0.0001
923 TYPE 2 DIABETES MELLITUS 2 0.0001
924 HYPERSENSITIVITY 11 0.0001
925 FLUID RETENTION 3 0.0001
926 NEOPLASM PROGRESSION 2 0.0001
927 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
928 HAEMORRHAGE 6 0.0001
929 ECZEMA 3 0.0001
930 PARAESTHESIA 9 0.0001
931 AMENORRHOEA 1 0.0001
932 INCORRECT DOSE ADMINISTERED 13 0.0001
933 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
934 NASOPHARYNGITIS 10 0.0001
935 OROPHARYNGEAL PAIN 5 0.0001
936 PAIN 33 0.0001
937 EPISTAXIS 4 0.0001
938 BLISTER 3 0.0001
939 EYE PAIN 3 0.0001
940 NEUROPATHY PERIPHERAL 5 0.0001
941 PRODUCT SUBSTITUTION ISSUE 3 0.0001
942 PALPITATIONS 6 0.0001
943 NASAL CONGESTION 3 0.0001
944 RASH 22 0.0001
945 PROSTATE CANCER 4 0.0000
946 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
947 HYPOACUSIS 2 0.0000
948 FEBRILE NEUTROPENIA 3 0.0000
949 ANGIOEDEMA 2 0.0000
950 NEOPLASM MALIGNANT 3 0.0000
951 COLITIS ULCERATIVE 2 0.0000
952 GASTROINTESTINAL DISORDER 4 0.0000
953 SKIN DISCOLOURATION 2 0.0000
954 ADVERSE EVENT 4 0.0000
955 BREAST CANCER 4 0.0000
956 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
957 DEVICE MALFUNCTION 3 0.0000
958 INJURY 3 0.0000
959 MULTIPLE SCLEROSIS 2 0.0000
960 JOINT SWELLING 5 0.0000
961 MYALGIA 7 0.0000
962 AGEUSIA 1 0.0000
963 HOT FLUSH 3 0.0000
964 ABDOMINAL PAIN LOWER 1 0.0000
965 FLUSHING 4 0.0000
966 PRURITUS 15 0.0000
967 ILLNESS 4 0.0000
968 ANAPHYLACTIC SHOCK 1 0.0000
969 INJECTION SITE BRUISING 3 0.0000
970 NEUTROPENIA 5 0.0000
971 INFLUENZA LIKE ILLNESS 3 0.0000
972 ARTHROPATHY 2 0.0000
973 ASTHMA 4 0.0000
974 DRUG WITHDRAWAL SYNDROME 3 0.0000
975 BLADDER CANCER 2 0.0000
976 DISCOMFORT 2 0.0000
977 FEELING HOT 2 0.0000
978 DRUG DOSE OMISSION 5 0.0000
979 DRY SKIN 4 0.0000
980 URTICARIA 5 0.0000
981 HEPATIC ENZYME INCREASED 2 0.0000
982 SINUSITIS 3 0.0000
983 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
984 THERAPY INTERRUPTED 2 0.0000
985 NO ADVERSE EVENT 5 0.0000
986 INJECTION SITE HAEMORRHAGE 2 0.0000
987 SKIN EXFOLIATION 2 0.0000
988 ADVERSE DRUG REACTION 2 0.0000
989 EMOTIONAL DISTRESS 2 0.0000
990 PRODUCT QUALITY ISSUE 2 0.0000
991 ACNE 1 0.0000
992 DRUG DEPENDENCE 2 0.0000